Tags

Type your tag names separated by a space and hit enter

T-type Ca2+ channel blockers suppress the growth of human cancer cells.
Bioorg Med Chem Lett. 2008 Jul 15; 18(14):3899-901.BM

Abstract

In order to further clarify the role of T-type Ca(2+) channels in cell proliferation, we have measured the growth inhibition of human cancer cells by using our potent T-type Ca(2+) channel blockers. As a result, KYS05090, a most potent T-type Ca(2+) channel blocker, was found to be as potent as doxorubicin against some human cancer cells without acute toxicity. Therefore, this letter provides the biological results that T-type calcium channel is important in regulating the important cellular phenotype transition leading to cell proliferation, and thus novel T-type Ca(2+) channel blocker presents new prospects for cancer treatment.

Authors+Show Affiliations

Research Institute for Basic Sciences and Department of Chemistry, College of Sciences, Kyung Hee University, 1 Hoegi-Dong, Dongdaemun-Gu, Seoul 130-701, Republic of Korea.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18585035

Citation

Heo, Jae Ho, et al. "T-type Ca2+ Channel Blockers Suppress the Growth of Human Cancer Cells." Bioorganic & Medicinal Chemistry Letters, vol. 18, no. 14, 2008, pp. 3899-901.
Heo JH, Seo HN, Choe YJ, et al. T-type Ca2+ channel blockers suppress the growth of human cancer cells. Bioorg Med Chem Lett. 2008;18(14):3899-901.
Heo, J. H., Seo, H. N., Choe, Y. J., Kim, S., Oh, C. R., Kim, Y. D., Rhim, H., Choo, D. J., Kim, J., & Lee, J. Y. (2008). T-type Ca2+ channel blockers suppress the growth of human cancer cells. Bioorganic & Medicinal Chemistry Letters, 18(14), 3899-901. https://doi.org/10.1016/j.bmcl.2008.06.034
Heo JH, et al. T-type Ca2+ Channel Blockers Suppress the Growth of Human Cancer Cells. Bioorg Med Chem Lett. 2008 Jul 15;18(14):3899-901. PubMed PMID: 18585035.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - T-type Ca2+ channel blockers suppress the growth of human cancer cells. AU - Heo,Jae Ho, AU - Seo,Han Na, AU - Choe,Yun Jeong, AU - Kim,Sujin, AU - Oh,Chun Rim, AU - Kim,Young Deuk, AU - Rhim,Hyewhon, AU - Choo,Dong Joon, AU - Kim,Jungahn, AU - Lee,Jae Yeol, Y1 - 2008/06/14/ PY - 2008/05/20/received PY - 2008/06/06/revised PY - 2008/06/11/accepted PY - 2008/7/1/pubmed PY - 2008/11/18/medline PY - 2008/7/1/entrez SP - 3899 EP - 901 JF - Bioorganic & medicinal chemistry letters JO - Bioorg Med Chem Lett VL - 18 IS - 14 N2 - In order to further clarify the role of T-type Ca(2+) channels in cell proliferation, we have measured the growth inhibition of human cancer cells by using our potent T-type Ca(2+) channel blockers. As a result, KYS05090, a most potent T-type Ca(2+) channel blocker, was found to be as potent as doxorubicin against some human cancer cells without acute toxicity. Therefore, this letter provides the biological results that T-type calcium channel is important in regulating the important cellular phenotype transition leading to cell proliferation, and thus novel T-type Ca(2+) channel blocker presents new prospects for cancer treatment. SN - 1464-3405 UR - https://www.unboundmedicine.com/medline/citation/18585035/T_type_Ca2+_channel_blockers_suppress_the_growth_of_human_cancer_cells_ DB - PRIME DP - Unbound Medicine ER -